MAY 2025LIFE SCIENCES REVIEW6T he clinical testing landscape in Japan is undergoing a quiet revolution, fueled by the region's growing leadership in cell and gene therapy. As researchers push forward with hundreds of trials--many now in late-phase development--the country's regulatory bodies are clearing new paths with designations like "Fast Track" for regenerative treatments. Decentralized and virtual models are opening doors to more diverse patient participation, while AI-driven analytics and real-time monitoring are tightening quality control in cell and gene therapy (CGT) manufacturing. Behind the scenes, another transformation is unfolding--this time in how pharmaceutical information is communicated. Today's translation workflows blend advanced neural machine translation tools with expert human oversight to ensure medical content isn't just accurate but culturally and contextually precise. As life sciences companies look to scale innovations beyond borders, these language services are proving essential in bridging scientific ambition with global execution.Driven by these trends, the life sciences market is projected to grow at a CAGR of approximately 11.75 percent from 2024 to 2032.In this edition of Life Sciences Review APAC, we provide insights into recent developments in the life science market and how companies offer services aligned with the latest trends.The magazine features a thought leadership article by Kazuto Yamada, Senior Director and Head of Clinical Development Planning and Supervising Five R&D Functions at Otsuka Pharmaceutical, highlighting how new technologies like digital biomarkers make clinical trials more patient-focused and efficient. It also features an article from Raymond R. Tjandrawinata, Director of Business Development and Scientific Affairs at Dexa Medica, who sheds light on the urgent need for better quality control in pharmaceuticals. The edition also features stories of life science companies delivering solutions that play a crucial role in driving innovation. One such company is MILS International, which specializes in advanced metabolic diagnostics using precision metabolomics and medical mass spectrometry. In this edition featuring Top Clinical Testing Services in Japan 2025, Top Cell and Gene Therapy Company in APAC 2025 and Top Pharmaceutical Translation Services in APAC 2025, we hope you find the right partner to meet your organization's needs. Let us know your thoughts!EDITORIALInnovation at Every StepCopyright © 2025 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreviewapac.comManaging EditorJeremy WilliamsMAY - 2025, Vol 06, Issue - 07 ( ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreviewapac.com VisualizersEmail:sales@lifesciencesreviewapac.comeditor@lifesciencesreviewapac.commarketing@lifesciencesreviewapac.comAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoCelestial JordanRobert Grey Smith
< Page 5 | Page 7 >